Ventricular tachycardia (VT) is considered as the main cause for syncope after myocardial infarction (MI). Multiple other causes have been reported. When left ventricular ejection fraction (LVEF) is low (35 %), the implantation of a defibrillator (ICD) is recommended. The mortality of these patients (pts) remains relatively high. The purpose of study was to evaluate the main causes implicated in syncope after MI and the clinical factors associated with the diagnosis.
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Methods: 363 pts, 307 men, 56 women, consecutively admitted for syncope and history of MI (> 1 month), without VT underwent echocardiography, Holter monitoring, head-up tilt-test, exercise testing, signal-averaged ECG, electrophysiological study (EPS) and evaluation of coronary status. They were followed 4±2 years.
Results:
The presumed cause of syncope was attributed after EPS to a ventricular arrhythmia in 151 pts (monomorphic VT 88, ventricular flutter or fibrillation (VF) 63), to a supraventricular tachyarrhythmia (SVT) in 39 pts, to conduction disturbances in 24 pts; 57 pts had several electrophysiological abnormalities: 26 had inducible VT or SVT and coronary ischemia; hypervagotonia was noted in 8 pts with induced VT or SVT. In the case of negative EPS, coronary ischemia alone was identified in 41 pts, hypervagotonia in 27pts. All studies were negative and syncope remains unexplained in 86 pts (24 %), mainly women (p<0.001)(27 % vs 20%***). Male gender (90 % vs 80 %**), a longer QRS duration (139±31 vs 115±28 ms**), a lower LVEF (36±11.5 vs 46±12 %***) and grade IVa,b of Lown on Holter ECG (53 vs 31.5 %***) were associated with VT induction. LVEF < 40 % and VT/VF induction were predictors of cardiac mortality, VT predictor of sudden death, low LVEF and advanced age predictors of death by heart failure.
Conclusions:
Several causes were frequently implicated; therefore complete evaluation remains necessary. Coronary ischemia was present in 18 % of patients with syncope after myocardial infarction; it was the sole cause in 11% of our population. Syncope remained unexplained more frequently in women than in men. Hypervagotonia explains syncope in only 8 % of our population.
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Prevalence and prognostic value of acute or subacute noncardiac conditions in patients with acute coronary syndrome Antonio Gaspar, Sérgio Nabais, Silvia Ribeiro, Catarina Vieira, Vitor Ramos, Sergia Rocha, Pedro Azevedo, Miguel Pereira, Alberto Salgado, Adelino Correia Hospital de Braga, Cardiologie, Braga, Portugal Introduction: Acute coronary syndrome (ACS) may be complicated by acute or subacute, major, noncardiac conditions. Few data are available regarding their exact prevalence and prognostic value. Purpose: We sought to determine the prevalence of major noncardiac conditions in ACS patients and their prognostic value.
Methods: A total of 1936 patients consecutively admitted with ACS were reviewed. We considered as acute or subacute, major, noncardiac conditions the following pathologies: pneumonia, decompensate chronic obstructive pulmonary disease, sepsis, stroke, anaemia, severe deterioration of renal function and active malignancy. We compared patients with at least one noncardiac condition to the others. Primary end points were in-hospital and 6-month mortality.
Results: Two hundred and three patients (10.5%) had at least one acute or subacute, major, noncardiac condition. Patients with a noncardiac condition were older, more frequently women and more often had diabetes mellitus, arterial hypertension and renal insufficiency (p <0.05). At admission, they more often presented with Killip class higher than one (p <0.05) but there were no differences regarding ACS presentation. They were less likely to be medicated with clopidogrel, β-blocker and statin (p <0.05) and to undergo invasive strategies and coronary revascularization (p <0.05). They had higher in-hospital and sixmonth mortality (19.6% vs 3.3% and 35.1% vs 7.7%, respectively; p <0.001). Multivariate analysis confirmed the presence of a noncardiac condition as an independent predictor of in-hospital mortality (OR=3,88; 95%CI=1,87-8,03) and six-month mortality (OR=2, 56; 95%CI=1, 42) .
Conclusions:
The presence of an acute or subacute, major, noncardiac condition was a powerful predictor of in-hospital and six-month mortality. Our results outline the importance of treating or preventing noncardiac conditions that negatively influence the prognosis of ACS patients.
Major bleeding still predicts death with a radial invasive strategy in NSTE-ACS : an analysis from theABOARD Study
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Methods:
In the multicenter randomized ABOARD study, 352 patients with acute coronary syndromes without ST-segment elevation were randomized for a "primary PCI" strategy or a strategy of intervention deferred to the next working day. No difference was observed in clinical outcomes between the two groups. Major bleeding complications (STEEPLE definitions) were correlated to 1 month mortality.
Results: Patients were treated by intense antiplatelet therapy: with a mean 660 mg (±268) loading of clopidogrel and 111 mg (±40) maintenance dose while 99% of the PCI patients receive abciximab the radial approach was predominant (84%).
During the first 30 days major bleeding complications occurred in 19 patients (5.4%) with transfusion in 16 patients (4.5%). Occurrence of major bleeding did not differ between immediate and delayed intervention. The most frequent overt bleeding complications were from the gastrointestinal tract. The composite of GI bleeding and occult bleeding (loss of Hb of >3 g/dL) represented n=11 (57.9%) of all major bleeding complications. Major bleeding was associated with a significantly higher peak of creatinine during hospitalization 170.16 µmol/L ± 169.34 vs. 97.05 µmol/L ± 56.96 (p=0.005) and a higher mortality rate 26.3% vs. 0.6%. After adjustment for all baseline characteristics, major bleeding was independently associated with an impressive increased hazard of death during the first 30 days (Odd ratio 75.7; 95% CI, 11.3 to 505.3; p<0.0001).
Conclusion:
In a population of radial catheterization for NSTEACS, GI bleeding is the most frequent bleeding complication. Despite the reduction of access site bleeding, major bleeding still remains a major independent predictor of mortality.
